Protection against CTL escape and clinical disease in a murine model of virus persistence

被引:16
|
作者
Kim, TS
Perlman, S
机构
[1] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA
[2] Univ Iowa, Interdisciplinary Program Immunol, Iowa City, IA 52242 USA
[3] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA
来源
JOURNAL OF IMMUNOLOGY | 2003年 / 171卷 / 04期
关键词
D O I
10.4049/jimmunol.171.4.2006
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CTL escape mutations have been identified in several chronic infections, including mice infected with mouse hepatitis virus strain JHM. One outstanding question in understanding CTL escape is whether a CD8 T cell response to two or more immunodominant CTL epitopes would prevent CTL escape. Although CTL escape at multiple epitopes seems intuitively unlikely, CTL escape at multiple CD8 T cell epitopes has been documented in some chronically infected individual animals. To resolve this apparent contradiction, we engineered a recombinant variant-of JHM that expressed the well-characterized gp33 epitope of lymphocytic choriomeningitis virus, an epitope with high functional avidity. The results show that the presence of a host response to this second epitope protected mice against CTL escape at the immunodominant JHM-specific CD8 T cell epitope, the persistence of infectious virus, and the development of clinical disease.
引用
收藏
页码:2006 / 2013
页数:8
相关论文
共 50 条
  • [21] Vaccine protection against functional CTL abnormalities in simian human immunodeficiency virus-infected rhesus monkeys
    McKay, PF
    Schmitz, JE
    Barouch, DH
    Kuroda, MJ
    Lifton, MA
    Nickerson, CE
    Gorgone, DA
    Letvin, NL
    JOURNAL OF IMMUNOLOGY, 2002, 168 (01): : 332 - 337
  • [22] A Replicating Cytomegalovirus-Based Vaccine Encoding a Single Ebola Virus Nucleoprotein CTL Epitope Confers Protection against Ebola Virus
    Tsuda, Yoshimi
    Caposio, Patrizia
    Parkins, Christopher J.
    Botto, Sara
    Messaoudi, Ilhem
    Cicin-Sain, Luka
    Feldmann, Heinz
    Jarvis, Michael A.
    PLOS NEGLECTED TROPICAL DISEASES, 2011, 5 (08):
  • [23] Persistence of immunological memory as a potential correlate of long-term, vaccine-induced protection against Ebola virus disease in humans
    Mclean, Chelsea
    Dijkman, Karin
    Gaddah, Auguste
    Keshinro, Babajide
    Katwere, Michael
    Douoguih, Macaya
    Robinson, Cynthia
    Solforosi, Laura
    Czapska-Casey, Dominika
    Dekking, Liesbeth
    Wollmann, Yvonne
    Volkmann, Ariane
    Pau, Maria Grazia
    Callendret, Benoit
    Sadoff, Jerry
    Schuitemaker, Hanneke
    Zahn, Roland
    Luhn, Kerstin
    Hendriks, Jenny
    Roozendaal, Ramon
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [24] IMMUNOTHERAPY OF MURINE LEUKEMIA .1. PROTECTION AGAINST FRIEND LEUKEMIA VIRUS-INDUCED DISEASE BY PASSIVE SERUM THERAPY
    COLLINS, JJ
    SANFILIPPO, F
    TSONGCHOU, L
    ISHIZAKI, R
    METZGAR, RS
    INTERNATIONAL JOURNAL OF CANCER, 1978, 21 (01) : 51 - 61
  • [25] Vectorized Expression of a Pan-Filovirus Bispecific Monoclonal Antibody in a Murine Model for Protection Against Ebola and Marburg Virus Challenge
    Campbell, Elena S. B.
    Cao, Wenguang
    Gillies, Arielle N.
    Pei, Yanlong
    Lopes, Jordyn A.
    Rghei, Amira D.
    Susta, Leonardo
    Banadyga, Logan
    Wootton, Sarah K.
    MOLECULAR THERAPY, 2024, 32 (04) : 193 - 193
  • [26] IgY antibodies against Ebola virus possess post-exposure protection in a murine pseudovirus challenge model and excellent thermostability
    Zhang, Yuan
    Wei, Yanqiu
    Li, Yunlong
    Wang, Xuan
    Liu, Yang
    Tian, Deyu
    Jia, Xiaojuan
    Gong, Rui
    Liu, Wenjun
    Yang, Limin
    PLOS NEGLECTED TROPICAL DISEASES, 2021, 15 (03):
  • [27] Lack of humoral immune protection against Treponema denticola virulence in a murine model
    Kesavalu, L
    Holt, SC
    Ebersole, JL
    INFECTION AND IMMUNITY, 1999, 67 (11) : 5736 - 5746
  • [28] Antibody-mediated protection against MERS-CoV in the murine model
    New, R. R. C.
    Moore, B. D.
    Butcher, W.
    Mahood, R.
    Lever, M. S.
    Smither, S.
    O'Brien, L.
    Weller, S. A.
    Bayliss, M.
    Gibson, L. C. D.
    Macleod, C.
    Bogu, M.
    Harvey, R.
    Almond, N.
    Williamson, E. D.
    VACCINE, 2019, 37 (30) : 4094 - 4102
  • [29] A MURINE T-CELL LYMPHOMA MODEL SHOWING PROTECTION AGAINST TUMOR-DEVELOPMENT AND TREATMENT OF ESTABLISHED DISEASE
    PEREZ, MI
    LOBO, FM
    IMAEDA, S
    EDELSON, RL
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1993, 100 (04) : 597 - 597
  • [30] A MURINE T-CELL LYMPHOMA MODEL SHOWING PROTECTION AGAINST TUMOR-DEVELOPMENT AND TREATMENT OF ESTABLISHED DISEASE
    PEREZ, MI
    LOBO, FM
    IMAEDA, S
    EDELSON, RL
    CLINICAL RESEARCH, 1993, 41 (02): : A505 - A505